"Emerging Fusion Protein Technologies Drive Innovation in Targeted Therapies Across Autoimmune, Cancer, Metabolic, and Cardiovascular Diseases" Boston, Dec. 11, 2025 (GLOBE NEWSWIRE) -- According to ...

The Fc fusion protein market thrives on innovative therapies targeting oncological and genetic disorders. Key opportunities lie in developing stable and soluble treatments, partnering with research ...

The Food and Drug Administration has approved more than 100 monoclonal antibodies to treat a range of diseases. Other antibodies are used by physicians to diagnose conditions or by scientists to ...

BUFFALO, N.Y., — Many childhood cancers start with a hijacking at the molecular level. A group of abnormal proteins known as fusion proteins aberrantly engage with a collection of proteins that ...

A study looking at the biophysical properties of an abnormal protein driving cancer cells is giving scientists new therapeutic clues for how to treat ependymoma, the third most common childhood brain ...

The Food and Drug Administration has approved more than 100 monoclonal antibodies to treat a range of diseases. Other antibodies are used by physicians to diagnose conditions or by scientists to ...

The immune system (T cell) attacks a human tumor cell. A newly developed molecule brings together two powerful immunotherapy strategies in one treatment. Researchers at the University of Basel and ...

Biotium, a leading provider of innovative fluorescent reagents and kits for life science research, announces the release of a new line of bright fluorescent ligands designed for flexible labeling of ...

This highlights an important preclinical model that could be successful in humans. The notoriously persistent, difficult-to-treat, lifelong and contagious virus—which insidiously attacks the ...